WOLTERS KLUWER 66.420 € (+0,97 %) STMICROELECTRONICS 43.370 € (+1,17 %) 
SOITEC 112.650 € (+5,68 %) 
SHELL PLC 38.130 € (+0,34 %) BNP PARIBAS ACT.A 89.010 € (-1,44 %) ATON 0.011 € (+89,66 %) CIECHARGEURSINVEST 8.450 € (-0,24 %) Vusion 133.500 € (-9,18 %) HERMES INTL 1 648.000 € (-1,55 %) LISI 60.200 € (+3,44 %) SEMCO TECHNOLOGIES 41.100 € (-2,38 %) FORVIA 10.160 € (-3,79 %) VIRBAC 378.500 € (0,00 %) EURONEXT 144.300 € (-0,82 %) RUBIS 34.060 € (-0,87 %) 
DSM FIRMENICH AG 64.400 € (-0,37 %) ABIVAX 96.000 € (-1,99 %) AIR LIQUIDE 188.360 € (+0,27 %) WENDEL 84.900 € (-0,53 %) ORANGE 17.650 € (-1,56 %) PROSUS 41.535 € (-0,04 %) EMEIS 14.260 € (+0,71 %) ENGIE 28.280 € (-1,39 %) ESSILORLUXOTTICA 185.700 € (-3,18 %) PLUXEE 12.230 € (+0,33 %) VIRIDIEN 154.500 € (+1,31 %) ARKEMA 61.700 € (0,00 %) AIRBUS 165.920 € (-1,33 %) VOPAK 41.320 € (+1,32 %) ALTEN 56.650 € (-0,79 %) ASM INTERNATIONAL 867.400 € (+1,86 %) RELX 31.100 € (+0,52 %) AXA 41.030 € (-0,63 %) EIFFAGE 135.250 € (-2,17 %) KPN KON 4.661 € (-0,13 %) MICHELIN 31.940 € (-0,56 %) SANOFI 80.080 € (-2,05 %) DASSAULT SYSTEMES 19.595 € (+1,71 %) SAINT GOBAIN 77.540 € (-0,62 %) CAPGEMINI 99.100 € (-1,54 %) AIR FRANCE -KLM 9.220 € (-3,80 %) 
FLOW TRADERS 28.220 € (+1,07 %) 
ARCELORMITTAL SA 50.480 € (-2,51 %) DELTA PLUS GROUP 40.700 € (-2,40 %) CHRISTIAN DIOR 443.800 € (-0,94 %) CRCAM LANGUED CCI 84.010 € (+0,01 %) CORBION 18.490 € (+3,76 %) ASML HOLDING 1 249.600 € (+2,33 %) VINCI 127.600 € (-2,63 %) AKZO NOBEL 52.300 € (-0,98 %) ABN AMRO BANK N.V. 29.110 € (+1,78 %) THALES 232.800 € (-4,08 %) ING GROEP N.V. 23.845 € (-0,69 %) HEINEKEN 66.860 € (-0,92 %) CA TOULOUSE 31 CCI 122.400 € (+2,00 %) ALTAREA 112.200 € (-1,58 %) ADYEN 975.100 € (+4,78 %) NEXITY 8.850 € (+1,55 %) ALFEN 12.120 € (+3,50 %) HYDROGEN REFUELING 1.920 € (+2,13 %) |
26/04/2026 10:20
EQS-Adhoc: Vitruvia Medical AG: Annual Results as of December 31, 2025EQS-Ad-hoc: Vitruvia Medical AG / Key word(s): Results / Full year/Results / Full year Vitruvia Medical AG: Annual Results as of December 31, 2025 Anglikon, April 26, 2026: Vitruvia Medical AG Reports First Profit in 2025 and Significantly Increases Revenue In 2025, Vitruvia Medical AG reported its first profit after taxes of CHF 308,670.73, compared to a loss of CHF 173,775.93 in the previous year. Our subsidiary LT technologies GmbH & Co. KG generated revenue of EUR 2,540,929, compared to EUR 2,016,279 in the previous year, representing an increase of +26%. On a consolidated basis, earnings before interest, taxes, and amortization (EBITA) improved from EUR 178,398 to EUR 277,215 (a 55% increase compared to the previous year). The investment in LT Technologies has outperformed expectations. The revenue and profit targets set for 2025 were more than met. For 2026, we anticipate continued growth in LT Technologies’ business activity, which will be reflected in its revenue and profit figures. About Vitruvia Medical AG: Vitruvia Medical AG is a Swiss investment company focused on the repair, production, and distribution of medical devices and surgical instruments. Vitruvia thus combines innovative and sustainable solutions for medical-technical progress, customer benefit, and economic success.
End of Inside Information 26-Apr-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
2315012 26-Apr-2026 CET/CEST Source : Webdisclosure.com |
||||||||||||||||||||||||||||||
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière